- Amended Statement of Beneficial Ownership (3/A)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

HSU LARRY

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/9/2008

3. Issuer Name and Ticker or Trading Symbol

IMPAX LABORATORIES INC [IPXL]

(Last) (First) (Middle)

C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
President and CEO /

(Street)

HAYWARD, CA 94544

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

12/9/2008

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	16543 ⁽¹⁾	D
Common Stock	2370568 ⁽¹⁾	I	By: The Hsu Family Trust
Common Stock	12749 ⁽¹⁾	I	By: Spouse

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:
( 1)	This Form 3/A is being filed to report 16,089 shares of Common Stock inadvertently omitted from Dr. Hsu's Form-3 filed on December 9, 2008, as well as to clarify 16,543 shares of Common Stock were held by Dr. Hsu directly, 2,370,568 shares of Common Stock were held by The Hsu Family Trust, and 12,749 shares of Common Stock were held by his spouse.

Remarks:
The filing of this Statement shall not be construed as an admission (a) the person filing this Statement is, for the purposes of Section 16 of Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, of (b) this Statement is legally required to be filed by such person.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
HSU LARRY C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD, CA 94544	X		President and CEO

Signatures
/s/ James J. Devlin, Jr., by Power-of-Attorney		4/14/2009
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.